AELIS FARMA
Desconocido
ICOD: Improving COgnition in Down syndrome
AELIS FARMA
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Cognitive disabilities in individuals with Down syndrome (DS), also known as Trisomy 21, have no approved pharmacological treatment and repr...
2021-01-21 - 2026-01-31 | Financiado
2021-01-21 - 2026-01-31 | Financiado
* No se disponen de datos de la empresa actual.